Ubigene Biosciences is co-founded by biological academics and elites from China, the United States, and France. We are located in Guangzhou Science City, Guangdong province, China, which serves as a global center for high technology and innovation. Ubigene Biosciences has 3000㎡ office areas and laboratories, focusing on gene editing, cell biology technology, and antibody validation. Ubigene has provided high-quality gene-editing services and products to scientists and researchers in more than 30 countries around the world, including gene-editing cell line services / Virus packaging / Plasmid construction / CRISPR Library construction / Gene-editing microorganism / EZ-editor™Gene-editing Series Products, etc. Also, Ubigene has an exclusive KO Cell Line Bank and Red Cotton™ gRNA Plasmid Bank.
Make genome editing easier is the goal of Ubigene. We will continue to dedicate our R&D to maintain a stable improvement of our services and products. Pragmatism, efficiency, integrity are our business principles. We are committed to providing the best gene-editing services and products to every customer who chooses us.
Innovatively improved from CRISPR/Cas9 technology, CRISPR-U™ has greatly improved the efficiency of gene cutting and homologous recombination, thus improving the gene-editing efficiency by 10-20 times.
Ubigene had optimized the microbial gene-editing vectors and process. The efficiency and accuracy are much higher than traditional methods. CRISPR-B™ can be used in gene editing of bacteria and fungi.
It is an automated gene-editing strategy design system. Combining with 3000 cases of gene-editing data, bioinformatics and information technology, Ubigene created this system to benefit researchers who work on gene editing. It integrates three well-known gene databases, and it is an intelligent gene-editing system for cell lines and microorganisms.
Ubigene provides antibody validation "gold standard" KO lysates. This platform is based on self-developed UBI-001 near-haploid cell line and 2000+ KO cell bank. With CRISPR-U™ and Red-cotton™ CRISPR gene-editing system, the mass production of high-quality KO cell lysates can be ahieved.
Ubigene launched the Red Cotton™ gene knockout project in 2021 by combining CRISPR-U™, Red Cotton™ CRISPR gene editing designer and EZ-editor™ series of products together. It is planned to build a knockout cell bank with 5000 KO cell lines in 2024.